Type 2 Diabetes

The GIP/GLP-1 receptor agonist tirzepatide significantly reduced HbA1c and body weight compared with insulin glargine for adults with type 2 diabetes at high cardiovascular risk, according to new data from the SURPASS trial program.

Chinese adults with type 2 diabetes achieved a 0.93% HbA1c reduction with 24 weeks of mulberry twig alkaloid therapy, an outcome comparable with use of the alpha-glucosidase inhibitor acarbose, according to data published in Diabetes Care.

Cultural diets, like the Mediterranean diet, are beneficial for people with diabetes, so it is important to incorporate culturally relevant foods into meal plans, according to experts.

The FDA granted breakthrough device designation for a first-in-class duodenal mucosal resurfacing intervention for adults with insulin-treated type 2 diabetes, according to an industry press release.

African Caribbean adults and those with a high HbA1c are more likely to have a nonlinear decline in kidney function that increases progression of end-stage renal disease in type 2 diabetes, according to study data.

Patient-centered interventions may help Black adults with type 2 diabetes living in inner cities overcome various cultural and environmental barriers to care, according to study findings.

A risk score may be able to identify adults with type 2 diabetes at high risk for major adverse limb events, including in those without a history of peripheral artery disease, according to a study published in Diabetic Medicine.

ATLANTA — Lifestyle modifications that can prevent or reverse conditions like obesity and prediabetes are equally important in lowering the associated risks for ocular manifestations.

Adults with type 2 diabetes who underwent bariatric surgery reported more energy, less fatigue and better general health compared with those assigned to medical therapy, according to new data from the STAMPEDE trial.

Adults with asthma and type 2 diabetes had lower counts of asthma exacerbations and symptoms after initiating treatment with a glucagon-like peptide-1 receptor agonist compared with other drugs for diabetes treatment intensification.